A thirty-nine-year survival with the Starr-Edwards mitral valve prosthesis

Submitted: January 26, 2016
Accepted: January 26, 2016
Published: January 26, 2016
Abstract Views: 608
PDF: 440
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

We report a case of a 57 year-old woman with Starr- Edwards model 6120 mitral valve replacement and Kay- Shiley bioprosthetic tricuspid valve replacement in 1968 at Niguarda Hospital in Milan. The mitral caged-ball has proved its excellent durability and its good hemodynamic performance in many patients, even if subject to high tendency to thrombosis. In literature there is no evidence of durability of this prosthesis longer than 35 years. Our patient after 39 years from mitral valve replacement lives a happy and fulfilling life (NYHA II), with no evidence of hemolysis, ball variance, symptomatic embolization or major bleeding.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Citations

How to Cite

Scardi, Sabino, Bruno Pinamonti, Michele Moretti, and Gianfranco Sinagra. 2016. “A Thirty-Nine-Year Survival With the Starr-Edwards Mitral Valve Prosthesis”. Monaldi Archives for Chest Disease 70 (1). https://doi.org/10.4081/monaldi.2008.434.